The first batch of the adjunct COVID therapy drug, 2-deoxy-D-glucose (2-DG) — developed by the Defence Research and Development Organisation (DRDO) along with Dr Reddy’s Laboratories (DRL), Hyderabad — was on May 17, 2021 released for emergency use.
from The Hindu - National https://ift.tt/3tTKmrN
Monday, May 17, 2021
Coronavirus live updates | Villagers in tribal-dominated Dungarpur succeed in containing virus infection https://ift.tt/eA8V8J
Related Posts:
Leprosy screening to be held in government schools: Health Minister
https://ift.tt/eA8V8J- Converting ship that ran aground in Vizag into a tourist spot to be a challenging task
https://ift.tt/eA8V8J
- Dak adalat on Dec. 22
https://ift.tt/eA8V8J
- Govt. tells employees not to put embarrassing posts on social media
https://ift.tt/eA8V8J
- Crafts Mela inaugurated
https://ift.tt/eA8V8J
0 comments:
Post a Comment